HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Antibodies against the envelope glycoprotein promote infectivity of immature dengue virus serotype 2.

Abstract
Cross-reactive dengue virus (DENV) antibodies directed against the envelope (E) and precursor membrane (prM) proteins are believed to contribute to the development of severe dengue disease by facilitating antibody-dependent enhancement of infection. We and others recently demonstrated that anti-prM antibodies render essentially non-infectious immature DENV infectious in Fcγ-receptor-expressing cells. Immature DENV particles are abundantly present in standard (st) virus preparations due to inefficient processing of prM to M during virus maturation. Structural analysis has revealed that the E protein is exposed in immature particles and this prompted us to investigate whether antibodies to E render immature particles infectious. To this end, we analyzed the enhancing properties of 27 anti-E antibodies directed against distinct structural domains. Of these, 23 bound to immature particles, and 15 enhanced infectivity of immature DENV in a furin-dependent manner. The significance of these findings was subsequently tested in vivo using the well-established West Nile virus (WNV) mouse model. Remarkably, mice injected with immature WNV opsonized with anti-E mAbs or immune serum produced a lethal infection in a dose-dependent manner, whereas in the absence of antibody immature WNV virions caused no morbidity or mortality. Furthermore, enhancement infection studies with standard (st) DENV preparations opsonized with anti-E mAbs in the presence or absence of furin inhibitor revealed that prM-containing particles present within st virus preparations contribute to antibody-dependent enhancement of infection. Taken together, our results support the notion that antibodies against the structural proteins prM and E both can promote pathogenesis by enhancing infectivity of prM-containing immature and partially mature flavivirus particles.
AuthorsJúlia M da Silva Voorham, Izabela A Rodenhuis-Zybert, Nilda Vanesa Ayala Nuñez, Tonya M Colpitts, Heidi van der Ende-Metselaar, Erol Fikrig, Michael S Diamond, Jan Wilschut, Jolanda M Smit
JournalPloS one (PLoS One) Vol. 7 Issue 3 Pg. e29957 ( 2012) ISSN: 1932-6203 [Electronic] United States
PMID22431958 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Antibodies, Monoclonal
  • Antibodies, Viral
  • E-glycoprotein, Dengue virus type 2
  • Immune Sera
  • Membrane Proteins
  • Opsonin Proteins
  • Protein Precursors
  • Viral Envelope Proteins
  • Furin
Topics
  • Animals
  • Antibodies, Monoclonal (immunology)
  • Antibodies, Viral (immunology)
  • Antibody-Dependent Enhancement (immunology)
  • Cell Line
  • Dengue Virus (classification, immunology, pathogenicity)
  • Furin (antagonists & inhibitors, immunology)
  • Immune Sera (immunology)
  • Membrane Proteins (immunology)
  • Mice
  • Mice, Inbred C57BL
  • Opsonin Proteins (immunology)
  • Protein Binding (immunology)
  • Protein Precursors (immunology)
  • Serotyping
  • Viral Envelope Proteins (immunology)
  • Virion (immunology)
  • West Nile Fever (immunology, virology)
  • West Nile virus (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: